Literature DB >> 33420898

DMP-1 promoter-associated antisense strand non-coding RNA, panRNA-DMP-1, physically associates with EGFR to repress EGF-induced squamous cell carcinoma migration.

Shigeki Suzuki1,2, Hang Yuan3, Shizu Hirata-Tsuchiya4, Kazuma Yoshida4, Akiko Sato3, Eiji Nemoto3, Hideki Shiba4, Satoru Yamada3.   

Abstract

Accumulating evidence suggests that specific non-coding RNAs exist in many types of malignant tissues, and are involved in cancer invasion and metastasis. However, little is known about the precise roles of non-coding RNAs in squamous cell carcinoma (SQCC) invasion and migration. Recently, the dentin matrix protein-1 (DMP-1) gene locus was identified as a transcriptionally active site in squamous cell carcinoma (SQCC) tissue and cells. However, it is unclear whether RNA associated with cell migration exist at the DMP-1 gene locus in SQCC cells. We identified a novel promoter-associated non-coding RNA in the antisense strand of DMP-1 gene locus, promoter-associated non-coding RNA (panRNA)-DMP-1, by the RACE method in SQCC cells and tissues, and characterized the functions of panRNA-DMP-1 in EGF-driven SQCC cell migration. The inhibition of endogenous panRNA-DMP-1 expression by specific siRNAs and exogenous over-expression of panRNA-DMP-1 resulted in increased and suppressed cellular migration toward EGF in SQCC cells, respectively, and nuclear expression of panRNA-DMP-1 was induced by EGF stimulation. Mechanistically, suppression of panRNA-DMP-1 expression increased EGFR nuclear localization upon EGF treatment and nuclear panRNA-DMP-1 physically interacted with EGFR, which was confirmed by RNA immunoprecipitation assay using a bacteriophage-delivered PP7 RNA labeling system. Furthermore, co-immunoprecipitation assay revealed that suppression of panRNA-DMP-1 stabilized EGFR interaction with STAT3, a known co-transcription factors of EGFR, to induce migratory properties in many cancer cells. Based on these findings, panRNA-DMP-1 is an EGFR-associating RNA that inhibits the EGF-induced migratory properties of SQCC possibly by regulating EGFR nuclear localization and EGFR binding to STAT3.

Entities:  

Keywords:  Dentin matrix protein-1; EGFR; Migration; Promoter-associated RNA; Squamous cell carcinoma

Mesh:

Substances:

Year:  2021        PMID: 33420898     DOI: 10.1007/s11010-020-04046-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration.

Authors:  A Mashberg
Journal:  Oral Oncol       Date:  2000-05       Impact factor: 5.337

2.  Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.

Authors:  N S Fedarko; A Jain; A Karadag; M R Van Eman; L W Fisher
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.

Authors:  Abdullah Karadag; Neal S Fedarko; Larry W Fisher
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

4.  Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.

Authors:  Kalu U E Ogbureke; Rafik A Abdelsayed; Harvey Kushner; Li Li; Larry W Fisher
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

Authors:  Sebastien J Hotte; Eric W Winquist; Larry Stitt; Sylvia M Wilson; Ann F Chambers
Journal:  Cancer       Date:  2002-08-01       Impact factor: 6.860

Review 6.  Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer.

Authors:  Akeila Bellahcène; Vincent Castronovo; Kalu U E Ogbureke; Larry W Fisher; Neal S Fedarko
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

7.  Survival after diagnosis of cancer of the oral cavity.

Authors:  Katayoun Sargeran; Heikki Murtomaa; Seyed Mohammad Reza Safavi; Miira M Vehkalahti; Olli Teronen
Journal:  Br J Oral Maxillofac Surg       Date:  2007-12-21       Impact factor: 1.651

8.  Small integrin-binding proteins as serum markers for prostate cancer detection.

Authors:  Alka Jain; Dianalee A McKnight; Larry W Fisher; Elizabeth B Humphreys; Leslie A Mangold; Alan W Partin; Neal S Fedarko
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

9.  Expression of Osteopontin in Oral Squamous Cell Carcinoma and its Surgical Margins-An Immunohistochemical Study.

Authors:  Vijaya Nirmala Subramani; Malathi Narasimhan; Muthukumar Thiyagarajan; Balu David Munuswamy; Logeswari Jayamani
Journal:  J Clin Diagn Res       Date:  2015-11-01

10.  Adhesive and migratory effects of phosphophoryn are modulated by flanking peptides of the integrin binding motif.

Authors:  Shigeki Suzuki; Seiji Kobuke; Naoto Haruyama; Hiroaki Hoshino; Ashok B Kulkarni; Fusanori Nishimura
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

View more
  2 in total

Review 1.  Epigenetics in susceptibility, progression, and diagnosis of periodontitis.

Authors:  Shigeki Suzuki; Satoru Yamada
Journal:  Jpn Dent Sci Rev       Date:  2022-06-17

Review 2.  Natural antisense transcripts as drug targets.

Authors:  Olga Khorkova; Jack Stahl; Aswathy Joji; Claude-Henry Volmar; Zane Zeier; Claes Wahlestedt
Journal:  Front Mol Biosci       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.